Unique business models reign

Friday, January 23, 2015

Invacare and ResMed, two of the industry’s few public companies, made the list of most read stories again in 2014, but it was a newcomer, Inogen, that nearly stole the top spot.

Inogen opened for public trading in February of last year and proceeded to wow investors during its subsequent earnings calls with its unique manufacturer-provider business model.

Both Inogen and ResMed say that the worst of competitive bidding is behind the HME industry.

Invacare made the list for its ongoing struggle to lift a consent decree imposed by the U.S. Food and Drug Administration. In 2014, the company also announced a number of changes to its executive leadership. 

Taking the top spot was AssuraMed, which bought a competitor of its Edgepark Medical Supply business unit in 2014. Previously, the company bought Invacare Supply Group. Like Inogen, AssuraMed has raised eyebrows with a unique business model that includes both distributor and provider business lines.

Rounding out the top stories is Brightree, which announced a rebrand in 2014 following numerous acquisitions inside and outside the HME industry.